The market is segmented based on Global Primary Care POC Diagnostics Market Segmentation By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, and Immunoassays), Prescription (Prescription-Based Testing and OTC Testing), End-User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Other End Users), Product (Glucose, Cardio-Metabolic, Infectious Disease, Coagulation, Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, and Other POC Products) – Industry Trends and Forecast to 2031
.
The Global Primary Care Poc Diagnostics Market size was valued at USD 17.30 USD Billion in 2023.
The Global Primary Care Poc Diagnostics Market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.
